You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

ICOSAPENT Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Icosapent, and when can generic versions of Icosapent launch?

Icosapent is a drug marketed by Apotex, Ascent Pharms Inc, Dr Reddys, Hikma, Humanwell Puracap, Onesource Specialty, Pharmobedient, Qilu, Teva Pharms Usa, Xiamen Lp Pharm Co, and Zydus Lifesciences. and is included in eleven NDAs.

The generic ingredient in ICOSAPENT is icosapent ethyl. There are twelve drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Icosapent

A generic version of ICOSAPENT was approved as icosapent ethyl by HIKMA on May 21^st, 2020.

Get Started Free

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ICOSAPENT?
What are the global sales for ICOSAPENT?
What is Average Wholesale Price for ICOSAPENT?

Summary for ICOSAPENT

US Patents:	0
Applicants:	11
NDAs:	11
Drug Prices:	Drug price information for ICOSAPENT
DailyMed Link:	ICOSAPENT at DailyMed

Drug patent expirations by year for ICOSAPENT

Drug Prices for ICOSAPENT

US Patents and Regulatory Information for ICOSAPENT

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex	ICOSAPENT ETHYL	icosapent ethyl	CAPSULE;ORAL	209437-001	Jun 30, 2021	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Zydus Lifesciences	ICOSAPENT ETHYL	icosapent ethyl	CAPSULE;ORAL	217656-001	Apr 20, 2023	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Hikma	ICOSAPENT ETHYL	icosapent ethyl	CAPSULE;ORAL	209457-002	Mar 8, 2023	AB	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.